Healthcare ❯ Pharmaceuticals

Obesity Treatments

Market Competition GLP-1 Drugs Wegovy Drug Development Weight Loss Medicines Weight Loss Medications Manufacturing Market Dynamics Biotech Companies Diabetes Treatments Medications Next-Generation Drugs Clinical Trials Weight Loss Drugs

Lilly's Rally Deepens as U.S. Access Deal Recasts Outlook for GLP‑1 Drugs

A U.S. access deal with capped Medicare costs shifts attention to approvals that would open coverage in 2026.

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws